Can I read The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial on EtoBox?
The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial by Fatemeh Sadat Hosseini; Alireza Malektojari; Sara Ghazizadeh; Mehdi Hassaniazad; Parivash Davoodian; Habib Dadvand; Amin Reza Nikpoor; Sara Nikoofal-Sahlabadi; Sara Kahoori; Mojtaba Sepandi; Soheil Hassanipour; Mohammad Fathalipour is a Medicine article available to read on EtoBox.
What is The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial about?
## Abstract ## Objectives We will evaluate the efficacy and safety of Ivermectin in patients with mild and moderately severe COVID-19. ## Trial design This is a phase 3, single-center, randomized, open-label, controlled trial with a 2-arm parallel-group design (1:1 ratio). ## Participants The Severe Acute Respiratory Syndrome Departments of the Shahid Mohammadi Hospital, Bandar Abbas, Iran, will screen for patients age ≥ 20 years and weight ≥35 kg for the following criteria: Inclusion criteria for patients with mild COVID-19 symptoms (outpatients) Diagnosed mild pneumonia using computed tomography (CT) and/or chest X-ray (CX-R) imaging, not requiring hospitalization. Signing informed consent. Inclusion criteria for patients with moderate COVID-19 symptoms (inpatients) Confirmed infection using PCR. Diagnosed moderate pneumonia using CT and/or CXR imaging, requiring hospitalization. Hospitalized ≤ 48 hours. Signing informed consent. Exclusion criteria Severe and critical pneumonia due to COVID-19. Underlying diseases, including AIDS, asthma, loiasis, and severe liver and kidney disease. Use of anticoagulants (e.g., warfarin) and ACE inhibitors (e.g., captopril). History of drug alle
Who reads The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Fatemeh Sadat Hosseini; Alireza Malektojari; Sara Ghazizadeh; Mehdi Hassaniazad; Parivash Davoodian; Habib Dadvand; Amin Reza Nikpoor; Sara Nikoofal-Sahlabadi; Sara Kahoori; Mojtaba Sepandi; Soheil Hassanipour; Mohammad Fathalipour
- Publisher
- Springer Science and Business Media LLC
- Published
- 2021
- Language
- EN
- Field
- Medicine (Health Sciences)